There were two poster sessions on Cancer Stem Cell Therapeutics at the 101st Annual Meeting of the American Association for Cancer Research (AACR). The sessions, Cancer Stem Cell Therapeutics 1 and Cancer Stem Cell Therapeutics 2, took place on the morning and afternoon of April 20, 2010 [FriendFeed entry].
Two posters presented in the 2nd session have been highlighted in a news release. See: Alchemia’s HyACT Technology Enhances the Killing of Cancer Stem Cell Populations in Breast and Colorectal Cancer, Business Wire, April 20, 2010 [FriendFeed entry]. One of these is Poster #4293: Evaluation of activated CD44 as a biological target in the eradication of breast cancer stem cells, by Vera J Evtimov and Tracey J Brown [Presentation Abstract]. The other is Poster #4278: HA-Irinotecan targeting of activated CD44 is an effective therapy for the eradication of putative colon cancer stem cells [Presentation Abstract].
Subscribe to:
Post Comments (Atom)
Posts
Alexey Bersenev tried to attend all of the sessions at AACR 2010 that covered cancer stem cells. See: Trends in cancer stem cells – identification, markers and assays. Notes from AACR 2010, April 24, 2010. (Also available via: http://bit.ly/cRRS8U).
ReplyDeleteAlexey Bersenev has posted more notes about the 101th annual meeting American Association of Cancer Research. See this post: Stem cells, cancer progression and metastasis (part V) - metastatic cascade driven by cancer stem cells, Hematopoiesis, April 29, 2010.
ReplyDelete